Kemocarb 150mg Injection (Carboplatin 150mg)

Kemocarb 150mg Injection 15 ml belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small cell lung cancer. It may sometimes be used to treat other cancers. Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

Kemocarb 150mg Injection 15 ml contains ‘Carboplatin’. Carboplatin acts by penetrating the cell wall and binding to the DNA of the cell, stopping the cell from naturally dividing and functioning, which ultimately destroys the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

Kemocarb 150mg Injection 15 ml is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously, or IV). You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Kemocarb 150mg Injection 15 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually continue taking Kemocarb 150mg Injection 15 ml for as long as your doctor has prescribed. Do not stop Kemocarb 150mg Injection 15 ml midway. Talk to your doctor before taking Kemocarb 150mg Injection 15 ml if you have severe allergic reactions to Kemocarb 150mg Injection 15 ml or other platinum-containing compounds, or if your suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Kemocarb 150mg Injection 15 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Kemocarb 150mg Injection 15 ml if you are pregnant or breastfeeding because this Kemocarb 150mg Injection 15 ml can cause harmful effects on the unborn baby. Both women and men using this Kemocarb 150mg Injection 15 ml should use birth control to avoid pregnancy.

Ovarian cancer and Small cell lung cancer

Kemocarb 150mg Injection 15 ml contains ‘Carboplatin’ belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or together with other chemotherapy drugs depending on the type of cancer you have.

Kemocarb 150mg Injection 15 ml is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously, or IV). Do not self-administer Kemocarb 150mg Injection 15 ml.The amount of Carboplatin you receive depends on many factors, including your height and weight, your general health or other health problems, and how your body responds to it. Your doctor will determine your dose and schedule.

Store in a cool and dry place away from sunlight

• Nausea
• Vomiting
• Diarrhoea
• Loss of appetite
• Hair loss and numbness
• Tingling
• Burning
• Pain in the hands or feet
• Nephrotoxicity at high doses
• Electrolyte disturbances
• Thrombocytopenia (low blood platelet count)
• Peripheral neuropathy (nerves malfunction)
• Leukopenia (low white blood cell count)